20220525-IMF-Finance_Vaccine_Equity_Funding_for_Day-Zero_of_the_Next_Pandemic_29页_513kb

Summary of "Financing Vaccine Equity: Funding for day-zero of the next pandemic"

Introduction

The paper argues that lack of timely financing significantly delayed vaccine deliveries to low- and middle-income countries (LMICs) during COVID-19. It proposes a "Pandemic Advance Commitment Facility" (PACF) with day-zero access to a credit line to ensure faster and equitable global responses in future pandemics.

Key Findings from COVID-19

• Delays in vaccine deliveries to LMICs were primarily due to later signing of purchase agreements, accounting for 60-75% of the delay.
• On average, LMICs ordered three to five months later than high-income countries, leading to delivery delays of 3.607 to 5.565 months.
• If ordered earlier in 2021, delays could be reduced by up to 75%.

Proposed Pandemic Advance Commitment Facility

• Core feature: Access to a credit line on day-zero (triggered by WHO pandemic declaration or threshold deaths), allowing LMICs to secure early orders.
• Design: Independent management team avoids political interference; funded by a credit line from a financier (e.g., bank, development agency).
• Operations: Focus on vaccines, tests, treatments, and PPE; includes investments in R&D and production capacity.

Credit Risk Management Options

• Option A: Donors provide legally binding pledges to cover risk.
• Option B: LMICs jointly guarantee the credit line.
• Option C: Private sector uses pandemic-linked bonds, with compensation from donors/ LMICs.
• Option D: Financier and shareholders retain all risk, potentially limiting capital availability for other uses.

Design Elements

• Diversification of supply sources to mitigate export restrictions.
• Clear allocation rules for free/subsidized coverage.
• Triggers for fund activation and deactivation based on objective criteria to prevent moral hazard.

Conclusion

Day-zero financing can achieve equitable pandemic responses by overcoming fundraising barriers. Existing donor commitments support a $20 billion credit line, with risk manageable through various options. The PACF complements other pandemic financing mechanisms.